サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ファーマ4.0市場：技術別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1351421

ファーマ4.0市場：技術別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Pharma 4.0 Market, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 288 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ファーマ4.0市場：技術別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

Pharma 4.0の市場規模は2022年に109億米ドルと評価され、2023年から2030年にかけてCAGR 17.7%で拡大します。

Pharma 4.0は、リアルタイムのデータ駆動型洞察力、予測モデリング、スマートシステムの相互接続性を活用することで、プロセスの合理化、製品品質の向上、機敏な意思決定プロセスの強化を目指します。最終的には、患者を中心としたヘルスケアの時代を切り開き、患者中心の持続可能なソリューションを提供することを目指しています。そうすることで、技術革新を取り入れ、医薬品業界における日々進化する課題と機会に効果的に対処することができるのです。

Pharma 4.0市場- 市場力学：

  • 医薬品開発を加速させ、新しい治療法をもたらすというプレッシャーの高まりが市場需要を促進
  • 製薬業界は、複雑な疾病に対処し、進化する患者のニーズに迅速に対応するための課題が山積しています。Pharma4.0の登場は新時代の到来を告げ、医薬品開発のより効率的な道筋、臨床試験の予測モデリング、生産プロセスの強化を提供します。この変革は、人工知能、機械学習、データ分析などの先進技術の統合にかかっています。
  • Pharma 4.0は、顕著な時間とコストの削減を実現するだけでなく、新たな健康危機、規制の変化、消費者の需要の変化への対応において、業界の適応性を高める。その結果、イノベーションが加速し、画期的な救命治療へのアクセスが向上する環境が醸成され、患者にとって医療の新時代が到来します。

ファーマ4.0市場-セグメンテーション分析：

  • 世界のPharma 4.0市場は、テクノロジー、アプリケーション、エンドユーザー、地理的地域を主要部門とする多面的なセグメンテーション構造を示しています。
  • テクノロジー分類の傘下では、市場は3つの異なるカテゴリーを定義している：クラウド・コンピューティング、人工知能、ビッグデータ分析、モノのインターネットです。注目すべきは、人工知能部門が圧倒的な優位性を主張し、市場内で優勢な勢力として台頭していることです。
  • Pharma 4.0は、人工知能（AI）の能力を活用し、医薬品部門に変革の時代をもたらします。AIを活用したアルゴリズムは、複雑なデータセットの解読、医薬品研究の迅速化、臨床試験結果の予測的洞察の提供、生産プロセスの最適化に役立っています。AIとPharma 4.0のこの共生関係は、意思決定の強化、イノベーションの高まり、患者中心のアプローチの採用を特徴とするパラダイムシフトを促進します。最終的には、この相乗効果により、生産性が向上するだけでなく、進化するヘルスケアのニーズに高度に対応できるヘルスケア・エコシステムが実現します。

Pharma 4.0市場-競合情勢：

Pharma 4.0の競合情勢は、既存大手製薬企業と革新的新興企業の融合を特徴とするダイナミックな場です。ファイザー、ノバルティス、ロシュのような業界の雄がデジタル変革を受け入れるために多大なリソースを投入する一方で、AI、データ分析、自動化の専門知識を持つニッチプレーヤーやテクノロジー新興企業の波が、破壊的ソリューションを導入することで頭角を現しています。

このような状況の中で注目すべき動向は、製薬企業とテクノロジープロバイダー間の協力体制です。製薬企業とテクノロジー・プロバイダーはパートナーシップや提携を結び、イノベーションの文化を育んでいます。急成長するPharma 4.0市場の競争は、堅牢なデータプラットフォーム、高度な分析能力、俊敏な製造システムの確立が中心となっています。これらの努力は、創薬の加速化、サプライチェーンの最適化、ヘルスケア・エコシステムの進化するニーズに対応した個別化ヘルスケアソリューションの提供により、競争力を付与することを目的としています。

目次

第1章 ファーマ4.0市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ファーマ4.0の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ファーマ4.0業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ファーマ4.0市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ファーマ4.0市場情勢

  • ファーマ4.0市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ファーマ4.0市場- テクノロジー別

  • 概要
    • セグメントシェア分析（テクノロジー別）
    • クラウドコンピューティング
    • 人工知能
    • ビッグデータ分析
    • モノのインターネット

第8章 ファーマ4.0市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • 創薬と開発
    • 臨床試験
    • 製造業

第9章 ファーマ4.0市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 製薬会社
    • バイオテクノロジー企業
    • CROとCMO

第10章 ファーマ4.0市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ファーマ4.0業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • Roche Holding AG
    • Novartis AG
    • Johnson &Johnson
    • GlaxoSmithKline plc
    • Sanofi SA
    • AstraZeneca plc
    • Merck &Co., Inc.
    • Eli Lilly and Company
    • AbbVie Inc.
    • Boehringer Ingelheim International GmbH
    • Takeda Pharmaceutical Company Limited
    • Bristol Myers Squibb Company
    • Moderna, Inc.
    • Regeneron Pharmaceuticals, Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Pharma 4.0 Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Pharma 4.0 Market, by Technology 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Pharma 4.0 Market, by Application 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Pharma 4.0 Market, by End-User 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Pharma 4.0 Market, by Region 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Pharma 4.0 Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Pharma 4.0 Market share and leading players, 2022
  • FIGURE Europe Pharma 4.0 Market share and leading players, 2022
  • FIGURE Asia Pacific Pharma 4.0 Market share and leading players, 2022
  • FIGURE Latin America Pharma 4.0 Market share and leading players, 2022
  • FIGURE Middle East and Africa Pharma 4.0 Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Pharma 4.0 Market share analysis by country, 2022
  • FIGURE Germany Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Pharma 4.0 Market share analysis by country, 2022
  • FIGURE India Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Pharma 4.0 Market share analysis by country, 2022
  • FIGURE Brazil Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Pharma 4.0 Market share analysis by country, 2022
  • FIGURE Saudi Arabia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1656

REPORT HIGHLIGHT

Pharma 4.0 Market size was valued at USD 10,900 Million in 2022, expanding at a CAGR of 17.7% from 2023 to 2030.

Pharma 4.0 represents the integration of cutting-edge digital technologies, data analytics, robotics, and artificial intelligence into the pharmaceutical industry, aligning with the principles of the fourth industrial revolution. This transformative concept aims to revolutionize various facets of the pharmaceutical sector, encompassing drug research, development, manufacturing, and patient care. Its overarching goals include bolstering operational efficiency, expediting innovation, optimizing supply chain operations, and facilitating the implementation of personalized medicine.

Pharma 4.0 aspires to streamline processes, elevate product quality, and empower agile decision-making processes by harnessing the power of real-time data-driven insights, predictive modeling, and the interconnectivity of smart systems. Ultimately, it strives to usher in an era of healthcare that revolves around the patient, delivering more patient-centric and sustainable solutions. In doing so, it embraces technological innovations to effectively address the ever-evolving challenges and opportunities within the pharmaceutical landscape.

Pharma 4.0 Market - Market Dynamics:

  • Increasing pressure to accelerate drug development and bring new therapies to propel market demand
  • The pharmaceutical industry grapples with mounting challenges in addressing intricate diseases and meeting evolving patient needs with expediency. The advent of Pharma 4.0 has ushered in a new era, offering more efficient avenues for drug development, predictive modeling for clinical trials, and enhanced production processes. This transformation hinges on the integration of advanced technologies such as artificial intelligence, machine learning, and data analytics.
  • Pharma 4.0 not only delivers notable time and cost savings but also enhances the industry's adaptability in responding to emergent health crises, regulatory shifts, and shifting consumer demands. Consequently, it fosters a climate of accelerated innovation and improved accessibility to groundbreaking, life-saving therapies, ushering in a new era of healthcare for patients.

Pharma 4.0 Market - Key Insights:

  • According to insights shared by our research analyst, the global Pharma 4.0 market is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 18.2% during the forecast period spanning from 2023 to 2030.
  • This industry's expansion is underpinned by significant factors, most notably the mounting pressure to expedite drug development processes and introduce novel therapies to market.
  • Within the context of Technology segmentation, Artificial Intelligence emerges as the standout category, capturing the majority of the market share for the year 2022.
  • Furthermore, in the realm of application segmentation, Clinical Trials takes the lead in 2022, underscoring the pivotal role of Pharma 4.0 in optimizing and expediting clinical research processes.
  • From a regional perspective, North America emerges as the primary revenue contributor in the year 2022, reflecting the region's commitment to embracing Pharma 4.0 as a means to drive innovation and enhance healthcare outcomes.

Pharma 4.0 Market- Segmentation Analysis:

  • The Global Pharma 4.0 Market exhibits a multifaceted segmentation structure, comprising Technology, Application, End-User, and Geographical Region as its primary divisions.
  • Under the umbrella of Technology classification, the market delineates three distinct categories: Cloud Computing, Artificial Intelligence, Big Data Analytics, and the Internet of Things. Remarkably, it is the Artificial Intelligence sector that asserts its dominance, emerging as the predominant force within the market.
  • Pharma 4.0 harnesses the capabilities of artificial intelligence (AI) to usher in a transformative era for the pharmaceutical sector. AI-powered algorithms are instrumental in deciphering complex datasets, expediting drug research, offering predictive insights into clinical trial outcomes, and optimizing production processes. This symbiotic relationship between AI and Pharma 4.0 fosters a paradigm shift characterized by enhanced decision-making, heightened innovation, and the adoption of patient-centric approaches. Ultimately, this synergy results in a healthcare ecosystem that is not only more productive but also highly responsive to evolving healthcare needs.

Pharma 4.0 Market- Competitive Landscape:

Pharma 4.0's competitive landscape is a dynamic arena characterized by the convergence of established pharmaceutical giants and innovative startups. While industry stalwarts like Pfizer, Novartis, and Roche commit substantial resources to embrace the digital transformation, a wave of niche players and technology startups with expertise in AI, data analytics, and automation are making their mark by introducing disruptive solutions.

In this landscape, a noteworthy trend is the collaborative spirit between pharmaceutical firms and technology providers. They are forging partnerships and alliances, fostering a culture of innovation. The competition in the burgeoning Pharma 4.0 market is centered on the establishment of robust data platforms, sophisticated analytics capabilities, and agile manufacturing systems. These endeavors aim to confer a competitive edge by accelerating drug discovery, optimizing supply chains, and delivering personalized healthcare solutions to meet the evolving needs of the healthcare ecosystem.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMA 4.0 MARKET KEY PLAYERS

  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Takeda Pharmaceutical Company Limited
  • Bristol Myers Squibb Company
  • Moderna, Inc.
  • Regeneron Pharmaceuticals, Inc.

GLOBAL PHARMA 4.0 MARKET, BY TECHNOLOGY

  • Cloud Computing
  • Artificial Intelligence
  • Big Data Analytics
  • Internet of Things

GLOBAL PHARMA 4.0 MARKET, BY APPLICATION

  • Drug Discovery and Development
  • Clinical Trials
  • Manufacturing

GLOBAL PHARMA 4.0 MARKET, BY END-USER

  • Pharmaceutical Companies
  • Biotechnology Companies
  • CROs and CMOs

GLOBAL PHARMA 4.0 MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Pharma 4.0 Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharma 4.0 Market Snippet by Technology
    • 2.1.2. Pharma 4.0 Market Snippet by Application
    • 2.1.3. Pharma 4.0 Market Snippet by End-User
    • 2.1.4. Pharma 4.0 Market Snippet by Country
    • 2.1.5. Pharma 4.0 Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharma 4.0 Key Market Trends

  • 3.1. Pharma 4.0 Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharma 4.0 Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharma 4.0 Market Opportunities
  • 3.4. Pharma 4.0 Market Future Trends

4. Pharma 4.0 Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharma 4.0 Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pharma 4.0 Market Landscape

  • 6.1. Pharma 4.0 Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharma 4.0 Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 7.1.2. Cloud Computing
    • 7.1.3. Artificial Intelligence
    • 7.1.4. Big Data Analytics
    • 7.1.5. Internet of Things

8. Pharma 4.0 Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Drug Discovery and Development
    • 8.1.3. Clinical Trials
    • 8.1.4. Manufacturing

9. Pharma 4.0 Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Biotechnology Companies
    • 9.1.4. CROs and CMOs

10. Pharma 4.0 Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharma 4.0 Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharma 4.0 Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharma 4.0 Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pharma 4.0 Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pharma 4.0 Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Pharma 4.0 Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Roche Holding AG
    • 11.2.3. Novartis AG
    • 11.2.4. Johnson & Johnson
    • 11.2.5. GlaxoSmithKline plc
    • 11.2.6. Sanofi S.A.
    • 11.2.7. AstraZeneca plc
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Eli Lilly and Company
    • 11.2.10. AbbVie Inc.
    • 11.2.11. Boehringer Ingelheim International GmbH
    • 11.2.12. Takeda Pharmaceutical Company Limited
    • 11.2.13. Bristol Myers Squibb Company
    • 11.2.14. Moderna, Inc.
    • 11.2.15. Regeneron Pharmaceuticals, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us